RAISE Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 30, 2021)
Renal Anemia Innovation Support and Expansion Act or the RAISE Act
This bill allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.
What just happenedMay 3, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 30, 2021
- May 3, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 30, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 30, 2021Committee
Referred to the Subcommittee on Social Security.
Social Security Subcommittee - Apr 30, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 30, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 30, 2021IntroReferralIntro-H
Introduced in House
- Apr 30, 2021IntroReferral1000
Introduced in House